Distinguishing Daratumumab from Endogenous Monoclonal Proteins in Serum from Multiple Myeloma Patients Using an Automated Mass Spectrometry System.
Saved in:
| Title: | Distinguishing Daratumumab from Endogenous Monoclonal Proteins in Serum from Multiple Myeloma Patients Using an Automated Mass Spectrometry System. |
|---|---|
| Authors: | Barnidge D; The Binding Site, part of Thermo Fisher Scientific, Rochester, MN, United States., Sakrikar D; The Binding Site, part of Thermo Fisher Scientific, Rochester, MN, United States., Kubicki T; Biological Sciences Division, University of Chicago, Chicago, IL, United States., Derman BA; Biological Sciences Division, University of Chicago, Chicago, IL, United States., Jakubowiak AJ; Biological Sciences Division, University of Chicago, Chicago, IL, United States., Lakos G; The Binding Site, part of Thermo Fisher Scientific, Rochester, MN, United States. |
| Source: | The journal of applied laboratory medicine [J Appl Lab Med] 2025 Mar 03; Vol. 10 (2), pp. 235-249. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 101693884 Publication Model: Print Cited Medium: Print ISSN: 2576-9456 (Print) Linking ISSN: 24757241 NLM ISO Abbreviation: J Appl Lab Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
